Latest ROE for Hims & Hers Health: -2.97% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-2.97%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Hims & Hers Health (HIMS) currently reports a ROE of -2.97%. That is below the Consumer Staples sector average of 14.3%. Use the charts on this page to explore Hims & Hers Health's ROE history and peer comparisons.
Hims & Hers Health's ROE of -2.97% is lower than the Consumer Staples sector average of 14.3%. That is roughly 120.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Hims & Hers Health's current -2.97% should be judged against Consumer Staples norms (sector average: 14.3%) and against HIMS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -2.97%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Consumer Staples average is 14.3%. From there, open related valuation or income-statement pages for Hims & Hers Health, and consider following HIMS for alerts when major investors trade the stock.
Hims & Hers Health is classified in the Consumer Staples sector. On ROE, it currently shows -2.97% versus a sector average near 14.3%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing HIMS with unrelated industries.